Public clinical trials have monitored adverse events and safety outcomes under controlled protocols
Garcia-Webb adds that even if you meet certain qualifications, your insurance still may not cover the medication
This leaves buyers gambling with unknown chemicals, and potentially their lives, in a market that one MP described as alarming
Market Statistics Key Takeaways By type of GLP-1 agonist drugs, the long-acting GLP-1 agonist segment dominated in 2025
After all the positives weve covered, its time for the pendulum to swing a little bit the other way
Common factors include stress, changes in weight, excessive exercise, illness, travel, and hormonal imbalances such as thyroid disorders or polycystic ovary syndrome (PCOS)